Targeted Therapeutics Research Award
American Lung Association/LUNGevity Foundation Discovery Award
Seyed Javad Moghaddam, MD
University of Texas MD Anderson Cancer Center
Houston
TX
Dr. Moghaddam is investigating how airway inflammation can lead to lung cancer. The factor NF-κβ is involved in both inflammation and carcinogenesis. Dr. Moghaddam’s hypothesis is that NF-κβ is a likely candidate for the promotion of lung cancer by inflammation in chronic obstructive pulmonary disease patients.